Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases

Zitta Barrella Harboe(Statens Serum Institut), Jens‐Ulrik Stæhr Jensen(University of Copenhagen), Dina Leth Møller(University of Copenhagen), Johannes Roth Madsen(University of Copenhagen), Mia Marie Pries‐Heje(Copenhagen University Hospital), Erik Sørensen(Copenhagen University Hospital), Cecilie Bo Hansen(Rigshospitalet), Rasmus Bo Hasselbalch(Gentofte Hospital), Andrea Browatzki(Copenhagen University Hospital), Sebastian Rask Hamm(University of Copenhagen), Henning Bundgaard(Copenhagen University Hospital), Torgny Wilcke(Gentofte Hospital), Laura Pérez‐Alós(Copenhagen University Hospital), Susanne Dam Nielsen(University of Copenhagen), Birgitte Lindegaard(University of Copenhagen), Sisse Rye Ostrowski(University of Copenhagen), José Juan Almagro Armenteros(Bristol-Myers Squibb (Germany)), Peter Kjeldgaard(Gentofte Hospital), Helene Priemé(Gentofte Hospital), Alexander Jordan(Gentofte Hospital), Kamille Fogh(University of Copenhagen), Ruth Frikke‐Schmidt(University of Copenhagen), Tor Biering‐Sørensen(Copenhagen University Hospital), Kasper Iversen(University of Copenhagen), Rafael Bayarri‐Olmos(Copenhagen University Hospital), Pradeesh Sivapalan(Gentofte Hospital), Peter Garred(University of Copenhagen), Linda Hilsted(University of Copenhagen), Saher Burhan Shaker(Gentofte Hospital), Line Dam Heftdal(University of Copenhagen)
BMJ Open Respiratory Research
July 1, 2022
Cited by 18


Related Papers

(untitled)
|Edinburgh Research Explorer (University of Edinburgh)|0|2.3k
SignalP 6.0 predicts all five types of signal peptides using protein language models
|Repository for Publications and Research Data (ETH Zurich)|2022|2.1k